Ningxia Zhongke Biotechnology Co Ltd - Class A

NEW
SHSE:600165 (China)   Class A
Â¥ 3.21 -0.12 (-3.6%) Sep 11
At Loss
P/B:
4.79
Market Cap:
Â¥ 5.19B ($ 773.43M)
Enterprise V:
Â¥ 5.33B ($ 795.09M)
Volume:
19.30M
Avg Vol (2M):
13.50M
Trade In:
Volume:
19.30M
At Loss
Avg Vol (2M):
13.50M

Business Description

Description
Ningxia Zhongke Biotechnology Co Ltd is engaged in the production and sales of activated carbon products, preparation and storage of stem cells, trade and other businesses, as well as lauric acid.
Name Current Vs Industry Vs History
Cash-To-Debt
14.37
Equity-to-Asset
0.46
Debt-to-Equity
0.01
Debt-to-EBITDA
-0.18
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
1.94
Distress
Grey
Safe
Beneish M-Score
-0.46
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI
65.87
9-Day RSI
65.38
14-Day RSI
64.95
3-1 Month Momentum %
-15.14
6-1 Month Momentum %
-35.73
12-1 Month Momentum %
-34.86

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
2.33
Quick Ratio
1.66
Cash Ratio
0.72
Days Inventory
99.82
Days Sales Outstanding
80.67
Days Payable
268.28

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-33.1
Shareholder Yield %
5.42
Name Current Vs Industry Vs History
Gross Margin %
-10.04
Operating Margin %
-33.37
Net Margin %
-10.3
EBITDA Margin %
-14.36
FCF Margin %
-134.15
OCF Margin %
-77.08
ROE %
-8.23
ROA %
-2.2
ROIC %
-7.94
3-Year ROIIC %
3.61
ROC (Joel Greenblatt) %
-4.2
ROCE %
-5.18
Years of Profitability over Past 10-Year
3
Name Current Vs Industry Vs History
PS Ratio
7.93
PB Ratio
4.79
Price-to-Tangible-Book
5.1
EV-to-EBIT
-73.78
EV-to-EBITDA
-73.78
EV-to-Revenue
10.6
EV-to-FCF
-7.9
Price-to-GF-Value
1.37
Price-to-Median-PS-Value
1.07
Earnings Yield (Greenblatt) %
-1.36
FCF Yield %
-13.02
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Ningxia Zhongke Biotechnology Co Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ¥) 503.261
EPS (TTM) (Â¥) -0.099
Beta -0.2178
3-Year Sharpe Ratio 0.22
3-Year Sortino Ratio 0.4
Volatility % 48
14-Day RSI 64.95
14-Day ATR (Â¥) 0.149995
20-Day SMA (Â¥) 3.145
12-1 Month Momentum % -34.86
52-Week Range (Â¥) 2.15 - 4.44
Shares Outstanding (Mil) 1,615.88

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Ningxia Zhongke Biotechnology Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Ningxia Zhongke Biotechnology Co Ltd Stock Events

Financials Calendars
Event Date Price (Â¥)
2.5:1 Stock Split 2015-10-12 11.28 (+0.00%)
1.6:1 Stock Split 1999-09-20 4.03 (-0.56%)
Show
Entries

Ningxia Zhongke Biotechnology Co Ltd Frequently Asked Questions

What is Ningxia Zhongke Biotechnology Co Ltd(SHSE:600165)'s stock price today?
The current price of SHSE:600165 is ¥3.21. The 52 week high of SHSE:600165 is ¥4.44 and 52 week low is ¥2.15.
When is next earnings date of Ningxia Zhongke Biotechnology Co Ltd(SHSE:600165)?
The next earnings date of Ningxia Zhongke Biotechnology Co Ltd(SHSE:600165) is .
Does Ningxia Zhongke Biotechnology Co Ltd(SHSE:600165) pay dividends? If so, how much?
Ningxia Zhongke Biotechnology Co Ltd(SHSE:600165) does not pay dividend.

Press Release

Subject Date
No Press Release